Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 14/20 | 0.74 |
| ▸ | TUBB | P07437 | 14/20 | 0.74 |
| ▸ | TUBA3C | P0DPH7 | 14/20 | 0.74 |
| ▸ | TUBA1B | P68363 | 14/20 | 0.74 |
| ▸ | TUBA4A | P68366 | 14/20 | 0.74 |
| ▸ | TUBB4B | P68371 | 14/20 | 0.74 |
| ▸ | TUBB3 | Q13509 | 14/20 | 0.74 |
| ▸ | TUBB2A | Q13885 | 14/20 | 0.74 |
| ▸ | TUBB8 | Q3ZCM7 | 14/20 | 0.74 |
| ▸ | TUBA3E | Q6PEY2 | 14/20 | 0.74 |
| ▸ | TUBA1A | Q71U36 | 14/20 | 0.74 |
| ▸ | TUBA1C | Q9BQE3 | 14/20 | 0.74 |
| ▸ | TUBB6 | Q9BUF5 | 14/20 | 0.74 |
| ▸ | TUBB2B | Q9BVA1 | 14/20 | 0.74 |
| ▸ | TUBB1 | Q9H4B7 | 14/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | XBP1 | P17861 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21465487 | 0.93 | TUBB4A (0.75) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21465586 | 0.91 | TUBB4A (0.72) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21465547 | 0.91 | TUBB4A (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL4319398 | 0.89 | TUBB4A (0.76) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29819733 | 0.89 | TUBB4A (0.76) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL25761908 | 0.88 | TUBB4A (0.78) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21465492 | 0.88 | TUBB4A (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL8938425 | 0.87 | TUBB4A (0.78) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21465477 | 0.87 | TUBB4A (0.67) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL16239970 | 0.86 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690824-B2 | Antibacterial compounds | THE GENERAL HOSPITAL CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690824-B2 | Antibacterial compounds | THE GENERAL HOSPITAL CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690824-B2 | Antibacterial compounds | THE GENERAL HOSPITAL CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-20210251958-A1 | Antibacterial Compounds | RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER | 2021-08-19 | — | — | US | disclosed |
| US-20210251958-A1 | Antibacterial Compounds | RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER | 2021-08-19 | — | — | US | disclosed |
| WO-2019199979-A1 | ANTIBACTERIAL COMPOUNDS | THE GENERAL HOSPITAL CORPORATION (US) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019199979-A1 | ANTIBACTERIAL COMPOUNDS | THE GENERAL HOSPITAL CORPORATION (US) | 2019-10-17 | — | — | WO | disclosed |
| US-5527819-A | TREATING AIDS | MERCK & CO., INC. (US) | 1996-06-18 | — | — | US | disclosed |
| EP-0686148-A4 | INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO INC (US) | 1996-02-07 | — | — | EP | disclosed |
| EP-0686148-A1 | INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO. INC. (US) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994019321-A1 | INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1994-09-01 | — | — | WO | disclosed |
| US-5225421-A | Leukotriene antagonists; cytoprotective agents | MERCK FROSST CANADA, INC. (CA) | 1993-07-06 | — | — | US | disclosed |
| EP-0275667-B1 | 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES | MERCK FROSST CANADA INC. (CA) | 1992-03-18 | — | — | EP | disclosed |
| US-5081138-A | Antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents | MERCK FROSST CANADA, INC. (CA) | 1992-01-14 | — | — | US | disclosed |
| EP-0275667-A1 | 3-hetero-substituted-N-benzyl-indoles | MERCK FROSST CANADA INC. (CA) | 1988-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690824-B2 | Antibacterial compounds | MRPL21, SPOUT1, BAX | TUBB4A 71/4885TUBB 10/4885TUBA3C 324/4885 |
| US-20210251958-A1 | Antibacterial Compounds | MRPL21, SPOUT1, BAX | TUBB4A 71/4885TUBB 10/4885TUBA3C 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.